Global Leader in National Drug Name Development
The Global Leader in
Drug Naming and Pharmaceutical Brand Naming
At Brand Institute, we understand that a drug name is not just a label – it’s a strategic and regulatory – critical decision. With over 30 years of expertise, we are the global leader in proprietary and nonproprietary name development, working in accordance with FDA naming guidance, USAN naming processes, and INN development standards. Our proven track record ensures that your pharmaceutical product names meet regulatory expectations and global market needs.
👉 Schedule your free consultation now!
👉 Schedule your free consultation now!
The Brand Institute Advantage
Industry-Leading Expertise
- Over 30 years of expertise in pharmaceutical naming and drug name development.
- 14 consecutive years leading global FDA product naming approvals and successful navigation of complex regulatory processes.
- Specialized knowledge of both FDA brand name guidance and proprietary name FDA guidance, ensuring smooth regulatory approvals.
Regulatory Excellence
- Our regulatory subsidiary (Drug Safety Institute) includes former naming officials from the FDA, EMA, Health Canada, AMA, and WHO, experts deeply familiar with FDA naming guidance, nonproprietary naming, and global health agency standards.
- Team members have co-authored critical regulatory guidelines on the USAN naming process and recommended International Nonproprietary Names (INN naming), providing unique insights into successful regulatory interactions.
- Comprehensive understanding of the nonproprietary naming of biological products, INN development, and best practices for integrating INN in pharmacovigilance
Proven Success
- Expert proprietary name development, USAN naming, and FDA naming services tailored to client-specific needs.
- Efficient USAN name search, research, and submission to ensure accuracy and regulatory compliance.
- Ongoing support, robust drug name research, and trademark analysis, with transparent pricing and no hidden fees.
Our Regulatory Advantage
Former Naming Officials
- Former leaders from FDA, EMA, Health Canada, AMA, and WHO personally involved in each INN naming and USAN generic name project, ensuring alignment with global regulatory expectations.
- Specialists in international nonproprietary names for pharmaceutical substances provide expertise on both generic (USAN name) and proprietary naming strategies.
Fully Compliant Methodology
- Methods continuously updated to align with FDA naming, global health agencies’ evolving guidelines, and latest best practices for proprietary name development and INN naming.
Tiered Name Recommendations
- Rigorous regulatory-based safety research helps teams effectively balance risk management, compliance with FDA naming guidance, and commercial appeal across both proprietary and nonproprietary naming initiatives.
Our Services
Strategy Services
Unmatched strategy expertise, defining and elevating your brand's impact in the market
Name Development
Diverse team of namers develop hand-crafted names, supported by industry’s most innovative technologies
Trademark Searches.
Experienced team of attorneys and paralegals perform efficient and comprehensive searches
Marketing Research
Online naming and visual identity research surveys, global panel of respondents, results benchmarked to historical norms
Regulatory Services
Industry-leading name safety research, regulatory strategy, reports, rebuttals, consults, and more
Visual Identity
Award-winning designers create dynamic logos, packaging and labelling, collateral material, and websites
Why Choose Brand Institute?
Our experts, our process, and our track record speak for themselves.
- Successfully partnered with over 1,500 organizations on more than 5,000 drug name creation projects across proprietary, generic, and biological pharmaceuticals.
- Proven experience in every aspect of pharmaceutical naming—from comprehensive FDA product naming compliance, USAN naming agency expertise, to navigating complex INN development processes.